Zosano Pharma Corporation ZSANQ OTC

Zosano Pharma Corporation (ZSANQ) reported revenue of $785,000 in its most recent fiscal year. The company reported a net loss of $30M in its most recent fiscal year, with earnings trending at 4.9%/yr. The net profit margin is -3836.2%, which is negative. The company has not reported a profit in any of the last 4 years tracked. The gross margin is -1.4% (low), with a -25.1pp trend over the period. With a market cap data available and MOAT composite score of 0/100, the company has a low competitive position.

Criteria proven by this page:

• GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (0/100, Fail) — the company has frequently reported losses. Looking at the full 10-year history, the company was profitable in 1 of 10 years — a mixed long-term record
• INCOME (10/100, Fail) — the company is currently operating at a loss
• MOAT (0/100, Fail) — limited competitive moat based on margins and scale

Overall SharesGrow Score: 27/100 with 1/5 criteria passed.